CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

4 min read

Atherosclerosis Treatment Algorithms for Heart Disease Evaluation

Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk of major adverse cardiac events (MACE).1 Until recently, though, there had been no clinically useful...

Read More »

3 min read

How AI-enabled CCTA Creates Value by Reducing Downstream Costs

Care quality is a pillar of the Quadruple Aim for a reason. Stakeholders across the healthcare ecosystem benefit when patients have access to the...

Read More »

4 min read

Understanding Your Heart Disease Risk

Heart disease is the cause of death for 700,000 Americans1 and nearly 17.9 million people worldwide every year.2 While some of these individuals...

Read More »
Cleerly’s precision heart care helps health systems

4 min read

Cleerly Value to Health Systems: Precision Heart Care Reduces Risk and Improves Patient Care

Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to...

Read More »
Cleerly's precision heart care creates value for health plans

2 min read

Cleerly Value to Health Plans: Precision Heart Care Reduces Waste and Improves Patient Experience

Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into...

Read More »
Cleerly’s precision heart care enables providers to improve patient outcomes & satisfaction

3 min read

Cleerly Value to Private Practice: Precision Heart Care Allows for Personalized Heart Disease Evaluation

Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease...

Read More »
CCTA scan results

2 min read

What to Expect with a CCTA Scan

Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA)...

Read More »
Cleerly at the American Heart Association Scientific Sessions 2022

3 min read

Better Defining Heart Disease Risk Through Proper Evaluation

Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in...

Read More »
Catching Bob's plaque early helped guide his personalized treatment and tracking of heart disease.

3 min read

Catching Plaque Early Guides Personalized Treatment and Tracking of Heart Disease

Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive...

Read More »

3 min read

How Cleerly Outperforms Stress Tests

Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.

Read More »